Answers are grounded in this paper and cite their sources.
Glioblastoma is classified as the most aggressive brain tumor due to its invasive nature and rapid progression. It is clinically treated using combinations of different chemotherapeutic agents, such as Temozolomide, Carmustine, and Lomustine, along with surgery and/or radiotherapy. GBM cells often develop resistance to traditional treatments, leading to a need for the development of new therapies. But due to the complexity of the tumor microenvironment and its limited representation in laboratory models, most newly developed drugs fail to pass clinical trials, highlighting the need for clinically relevant preclinical testing models. Clinically relevant models would incorporate GBM cells in a three-dimensional setting that mimics the in vivo cancer environment and include key features such as the tumor microenvironment and the blood-brain barrier. This narrative review aims to identify 3D cell culture protocols that incorporate the tumor into such an environment and to assess their potential as models for testing glioblastoma treatments. A comprehensive search on Google Scholar and PubMed using the keywords Glioblastoma organoids”, “Brain Organoids”, “Glioblastoma 3D cell culture”, “Brain 3D cell culture”, and “Advances in brain cell culture” was done to identify published research work. The PRISMA 2020 guidelines were used to select the papers. The inclusion of the scientific research articles into the study was based on the presence or absence of brain tumor organoids/spheroids and/or cerebral organoids. After shortlisting, 28 studies were analyzed for the review, and the extracted data were put in a Table. The co-culture of cerebral organoids with GBM cells or Glioblastoma stem cells (GSCs)-based spheroids was the most common protocol used in the studies (38%). 14.3% of the studies reported the in vitro establishment of the BBB, and 50% of these studies used bioprinting and microfluidics-based approaches. 68% of the total studies included patient-derived samples, and preservation of patient-specific heterogeneity in the 3D models was also reported. This literature review provides a detailed analysis and summary of the different 3D cell culture techniques that have been developed to study the in vitro effects of the TME and BBB on drug treatment. The findings of this review will help researchers gain a comprehensive understanding of the different types of 3D brain cell culture models, including their design, biological relevance, and translational potential. By critically evaluating current methodologies, applications, and limitations, this review provides a consolidated framework to guide model selection for neuroscience research, disease modelling, and drug screening. Furthermore, the insights presented may support the advancement of more physiologically relevant in vitro brain models and inform future research directions toward improved reproducibility and clinical translation.
No takes yet. Share an insight, caveat, or question.
Sajjad et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: